Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

FORTUNE BAY GRANTS ANNUAL EQUITY INCENTIVE AWARDS AND...

December 6, 2025

Finlay Minerals Enters into Earn-In Agreements with Freeport...

April 18, 2025

Blue Jay Gold: Building the Next Multi-million-ounce Gold...

October 8, 2025

Ganfeng Chairman’s Forecast Sparks Lithium Price Surge in...

November 19, 2025

Group Eleven Announces Uplisting to OTCQB Market

May 24, 2025

Crypto Market Recap: Trump Media Files for Third...

July 14, 2025

Successful $1.8m Placement to Accelerate WA Gold Strategy

December 3, 2025

Finlay Minerals Receives TSX Venture Exchange Approval for...

May 3, 2025

Top 5 Silver News Stories of 2025

December 30, 2025

Homerun Resources

August 20, 2025